Skip to the main content

PHARMAOVERSEAS

Total Awarded$1.8MSee the contracts
Contract Awards17
Award Year2019

About PHARMAOVERSEAS

No description has been published for this company. If it is yours you can claim the profile and propose one. A member of staff reads every claim.

Contract Awards

17 public contracts recorded as awarded to PHARMAOVERSEAS, worth $1.8M in total.

Source for every entry below: World Bank Contract Awards Dataset (DS00005)

Oct 21, 2019Egypt
procurement of hepatitis C drugs$101K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-123276-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Oct 21, 2019Egypt
Procurement of hepatitis C drugs$102K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-123295-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Oct 21, 2019Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$101K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-123294-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Oct 21, 2019Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$101K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-123287-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Oct 21, 2019Egypt
This is a fixed dose combination drug. Each tablet contains 400 mg of sofosbuvir and 100 mg of velpatasvir.$100K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-123284-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Jul 22, 2019Egypt
Hepatitis c drugs$110K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-115751-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Jul 22, 2019Egypt
Hepatitis c drugs$108K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-115746-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Jul 22, 2019Egypt
Purchase of hepatitis c drugs$109K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-115736-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Jul 22, 2019Egypt
Purchase of hepatitis c drugs$106K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference MOHP-115253

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Jul 22, 2019Egypt
Purchase of hepatitis c drugs$109K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference MOHP-115204

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Show the remaining 7 awards on this page
Jul 22, 2019Egypt
alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs$107K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-115706-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Jul 22, 2019Egypt
alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs$108K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-115784-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Jul 22, 2019Egypt
alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs$105K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-115723-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Jul 22, 2019Egypt
alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs$107K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-115755-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Jul 22, 2019Egypt
all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs$106K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference EG-MOHP-115764-GO-RFQ

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Jul 22, 2019Egypt
all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs$107K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference MOHP-115222

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Jul 22, 2019Egypt
all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs$107K

Awarded by Government of Egypt, Arab Republic of (World Bank-financed, project P167000)

Reference MOHP-115211

Verify at source

Project P167000 - Transforming Egypt's Healthcare System Project

Is this you?

Claiming starts a review. A member of staff reads it, and nothing on this profile changes until they decide.

Claim this business
Report an error

Quick Facts

CountryEgypt